Abstract:Purpose: The human mimecan/osteoglycin promoter contains multiple interferon-stimulated response elements (ISRE) and interferon-gamma-activation sites (GAS). ISRE and GAS motifs are present in a variety of interferon (IFN)-inducible genes. The purpose of this study was to investigate whether IFN-gamma affects mimecan gene expression and, if so, to determine the cis-elements and transcription factors that mediate its action. Methods: Electrophoretic mobility shift assay (EMSA) was used to investigate whether nuclear proteins from IFN-gamma-treated cells bind to regions of the human mimecan promoter containing ISRE sites. Incubation of nuclear extracts with specific antibodies was used to identify transcription factors that bind to these sites. Transcriptional activity of the promoter was evaluated by transient transfections of human mimecan promoter/luciferase reporter constructs into corneal keratocytes and non-corneal cells. Co-transfection experiments were used to study the role of transcription factors that bind ISRE elements in the promoter and mediate the IFN-gamma response. Expression of mRNAs was analyzed by reverse transcription-polymerase chain reaction. Results: Using probes that correspond to two ISRE sites located in the first intron of the human mimecan gene, we detected specific DNA-protein complexes with nuclear extracts from IFN-gamma-treated cells. Formation of DNA-protein complexes was abrogated by competition with unlabeled probe and one of the complexes was supershifted by the anti-interferon regulatory factor-1 (IRF-1) antibody. Interestingly, when probe that corresponds to a conserved E-box (CACATG) in the proximal promoter and nuclear extracts from IFN-gamma-treated cells were used in EMSA, increased binding of upstream stimulatory factor-1 (USF-1) was observed. Co-transfection of a mimecan promoter construct that contained the entire first intron with IRF-1, or with both IRF-1 and USF-1 expression plasmids, suppressed luciferase activity of the promoter in corneal keratocytes and T-47D cells. In contrast, co-transfection experiments with IRF-2, or with both IRF-2 and USF-1, led to increased luciferase activity of the same promoter construct. RT-PCR analyses demonstrate that IFN-gamma rapidly and transiently suppresses mimecan expression and induces IRF-1 and IRF-2 mRNAs in bovine corneal keratocytes. Conclusions: IRF-1 binds to ISRE sites, located in the first intron of the human mimecan gene, and negatively regulates mimecan expression at the level of transcription. Consistent with these observations, an inverse correlation between the expression of mimecan and IRF-1 in bovine corneal keratocytes and non-corneal cells was demonstrated. IRF-2 positively regulates mimecan transcription in corneal keratocytes. Because the intact E-box in the proximal promoter was required for IRF-1 and IRF-2 effects on mimecan transcription, potential direct or indirect interactions between USF-1 and IRF-1 and IRF-2 are likely.

The mimecan gene expressed in human pituitary and regulated by pituitary transcription factor-1 as a marker for diagnosing pituitary tumors.

Antibody Preparation and Expression Analysis of a New Protein Mimecan in Pituitary Tumors

Mimecan in Pituitary Corticotroph Cells May Regulate Acth Secretion and the Hpaa

Different Expression of Mimecan As a Marker for Differential Diagnosis Between NSCLC and SCLC

Differential expression of mimecan and thioredoxin domain-containing protein 5 in colorectal adenoma and cancer: a proteomic study.

Pit-1 Mrna And Protein Expression In Human Pituitary Adenomas

The bovine mimecan gene. Molecular cloning and characterization of two major RNA transcripts generated by alternative use of two splice acceptor sites in the third exon

Expression and Prognostic Value of PIM-1 Kinase in Gliomas.

Integrated in Silico–In Vitro Identification and Characterization of the SH3-Mediated Interaction Between Human PTTG and Its Cognate Partners in Medulloblastoma

PIM-1 Mrna Expression is a Potential Prognostic Biomarker in Acute Myeloid Leukemia

Mimecan is involved in aortic hypertrophy induced by sinoaortic denervation in rats

The Experimental Study of Mirna in Pituitary Adenomas.

Interferon-gamma regulation of the human mimecan promoter

Relationship Between NF-κB, MMP-9, and MICA Expression in Pituitary Adenomas Reveals a New Mechanism of Pituitary Adenomas Immune Escape

The expression level and correlation of MMP-9 and IL-17 in pituitary tumor tissue

MicroRNA-30d Target TIMP3 Induces Pituitary Tumor Cell Growth and Invasion.

The Expression of Maspin in Mucoepidermoid Carcinoma of Salivary Gland and Its Cfinical Significance

Overexpression of the Pituitary Tumor Transforming Gene Upregulates Metastasis in Malignant Neoplasms of the Human Salivary Glands.

A Comprehensive Expression Profile Of Micrornas In Porcine Pituitary

Expression of Pim-1 in Tumors, Tumor Stroma and Tumor-Adjacent Mucosa Co-Determines the Prognosis of Colon Cancer Patients.

High Expression of PAMR1 Predicts Favorable Prognosis and Inhibits Proliferation, Invasion, and Migration in Cervical Cancer.